Published in Histopathology on March 03, 2011
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis. Proc Natl Acad Sci U S A (2013) 2.12
The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Oncogene (2012) 0.94
Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. PLoS Genet (2014) 0.86
Expression of activator protein-1 (AP-1) family members in breast cancer. BMC Cancer (2013) 0.84
Old players with a newly defined function: Fra-1 and c-Fos support growth of human malignant breast tumors by activating membrane biogenesis at the cytoplasm. PLoS One (2013) 0.82
Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties. J Cancer Res Clin Oncol (2015) 0.77
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling. BMC Cancer (2015) 0.75
A functional SNP rs1892901 in FOSL1 is associated with gastric cancer in Chinese population. Sci Rep (2017) 0.75
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol (2006) 25.12
Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol (1998) 11.84
AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer (2003) 8.88
Transcription factors as targets for cancer therapy. Nat Rev Cancer (2002) 7.27
In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clin Cancer Res (2009) 4.81
EGFR associated expression profiles vary with breast tumor subtype. BMC Genomics (2007) 3.35
ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell (2003) 3.28
ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell (2010) 3.03
The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer (2005) 2.63
Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee. Cancer (1997) 2.60
Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol (1998) 2.22
Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol (2008) 2.13
Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res (2001) 2.01
FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene (2005) 1.74
Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res (2009) 1.74
Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology (2007) 1.57
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.46
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene (1999) 1.42
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathology (2006) 1.39
The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast. Mod Pathol (2002) 1.35
Fra-1 a target for cancer prevention or intervention. Gene (2006) 1.35
Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am J Pathol (2007) 1.25
Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol (2003) 1.18
The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. Oncogene (2009) 1.17
FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol (1998) 1.17
The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res Treat (2004) 1.14
Her-2/neu gene amplification in ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev (2002) 1.06
Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene. Mol Immunol (2007) 1.04
Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells. Int J Cancer (2008) 1.03
FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. BMC Cancer (2007) 1.03
The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials. Oncogene (2002) 0.98
Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution. J Biol Chem (2010) 0.96
Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene (2003) 0.94
An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy. BMC Cancer (2006) 0.91
Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells. Ann Surg Oncol (2009) 0.88
Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma. Int J Exp Pathol (2005) 0.85
Aberrant expression of Fra-1 in estrogen receptor-negative breast cancers and suppression of their propagation in vivo by ascochlorin, an antibiotic that inhibits cellular activator protein-1 activity. J Antibiot (Tokyo) (2007) 0.81
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res (2005) 1.47
Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res (2005) 1.46
Detection of micrometastases in pN0 non-small cell lung cancer: an alternative method combining tissue microarray and immunohistochemistry. J Bras Pneumol (2008) 1.41
GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. Molecules (2010) 1.27
Computed tomography guided needle biopsy: experience from 1,300 procedures. Sao Paulo Med J (2006) 1.23
Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts. Int J Cancer (2009) 1.19
Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol (2009) 1.12
Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Oncol Rep (2010) 1.11
Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Arch (2008) 1.01
Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer (2010) 1.00
Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer. Int J Oncol (2010) 1.00
Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. PLoS One (2013) 0.99
HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer (2012) 0.99
25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer. J Steroid Biochem Mol Biol (2006) 0.98
Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas. Clinics (Sao Paulo) (2012) 0.98
Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer. J Clin Endocrinol Metab (2010) 0.97
Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors. Transl Oncol (2010) 0.97
High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res (2010) 0.97
Primary oral mucosal melanoma: a series of 35 new cases from South America. Am J Dermatopathol (2009) 0.97
Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. Oral Oncol (2009) 0.97
Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Endocr Relat Cancer (2013) 0.96
Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome. Hum Pathol (2013) 0.94
Expression of cancer/testis antigens is correlated with improved survival in glioblastoma. Oncotarget (2013) 0.94
Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands. Oral Oncol (2005) 0.93
Sex with animals (SWA): behavioral characteristics and possible association with penile cancer. A multicenter study. J Sex Med (2011) 0.93
Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol (2011) 0.93
CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck (2011) 0.92
High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer (2011) 0.92
Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer. J Transl Med (2013) 0.92
Cytokeratin-based CTC counting unrelated to clinical follow up. J Thorac Dis (2013) 0.91
Front pattern of invasion in squamous cell carcinoma of the penis: new prognostic factor for predicting risk of lymph node metastases. Urology (2006) 0.90
Prognostication of OCT4 isoform expression in prostate cancer. Tumour Biol (2013) 0.90
Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture. Virchows Arch (2003) 0.89
Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk. Clinics (Sao Paulo) (2011) 0.89
Presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) in ameloblastomas correlate with rupture of the osseous cortical. Pathol Oncol Res (2008) 0.89
Developing human minor salivary glands: morphological parallel relation between the expression of TGF-beta isoforms and cytoskeletal markers of glandular maturation. Virchows Arch (2007) 0.88
TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer (2013) 0.88
Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma. Gastric Cancer (2008) 0.87
Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma. Oral Oncol (2010) 0.87
Multiple mutations in the Kras gene in colorectal cancer: review of the literature with two case reports. Int J Colorectal Dis (2011) 0.87
Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch Otolaryngol Head Neck Surg (2008) 0.87
[Immunophenotype and evolution of breast carcinomas: a comparison between very young and postmenopausal women]. Rev Bras Ginecol Obstet (2009) 0.87
SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis. Cancer Lett (2009) 0.87
Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance. Int Braz J Urol (2012) 0.87
Clinical utility of KAP-1 expression in thyroid lesions. Endocr Pathol (2013) 0.87
Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy. Arch Otolaryngol Head Neck Surg (2009) 0.86
Absence of TGF-βRII predicts bone and lung metastasis and is associated with poor prognosis in stage III breast tumors. Cancer Biomark (2012) 0.86
Synchronous ameloblastoma and orthokeratinized odontogenic cyst of the mandible. J Oral Pathol Med (2006) 0.86
Caspase expression in oral squamous cell carcinoma. Head Neck (2010) 0.86
Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma. Histopathology (2010) 0.85
Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray. Hum Pathol (2010) 0.85
MGMT and PTEN as potential prognostic markers in breast cancer. Exp Mol Pathol (2011) 0.85
Activation of sonic hedgehog signaling in oral squamous cell carcinomas: a preliminary study. Hum Pathol (2011) 0.85
Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer. Endocr Relat Cancer (2012) 0.85
Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors. Tumour Biol (2011) 0.85
Human Papilloma Virus: Prevalence, distribution and predictive value to lymphatic metastasis in penile carcinoma. Int Braz J Urol (2013) 0.84
Ezrin expression as a prognostic marker in colorectal adenocarcinoma. Pathol Oncol Res (2011) 0.84
Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma. Histopathology (2010) 0.84
Dedifferentiated liposarcoma of the oral cavity with angiosarcomatous dedifferentiation. Virchows Arch (2005) 0.83
E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology (2006) 0.83
CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma. World J Urol (2011) 0.83
Characterization of sociodemographic and clinicopathological features in Brazilian patients with vulvar squamous cell carcinoma. Gynecol Obstet Invest (2012) 0.83
A clinical, pathologic, and molecular study of p53 and murine double minute 2 in penile carcinogenesis and its relation to prognosis. Hum Pathol (2011) 0.83
Langerhans cell histiocytosis and its relationship with Epstein-Barr virus. Hum Pathol (2006) 0.83
Hyaluronidase splice variants are associated with histology and outcome in adenocarcinoma and squamous cell carcinoma of the lung. Hum Pathol (2011) 0.82
[Basal-like breast cancers: clinicopathological features and outcome]. Rev Assoc Med Bras (2009) 0.82
EBV-associated polymorphic posttransplant lymphoproliferative disorder presenting as gingival ulcers. Int J Surg Pathol (2009) 0.82
The value of a tumor bank in the development of cancer research in Brazil: 13 years of experience at the a C camargo hospital. Biopreserv Biobank (2012) 0.82
An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas. PLoS One (2013) 0.82
Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma? Urology (2007) 0.82
Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and angiogenesis in chondrosarcoma and their relation to prognosis. J Bone Joint Surg Am (2010) 0.82
Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast. Transl Oncol (2012) 0.82
Loss of RKIP expression during the carcinogenic evolution of endometrial cancer. J Clin Pathol (2011) 0.82
Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection. J Surg Oncol (2011) 0.82
Deregulated expression of superoxide dismutase-2 correlates with different stages of cervical neoplasia. Dis Markers (2011) 0.81
Significance of topoisomerase IIIβ expression in breast ductal carcinomas: strong associations with disease-specific survival and metastasis. Hum Pathol (2010) 0.81
Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside. J Transl Med (2012) 0.81
Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer. Clinics (Sao Paulo) (2011) 0.81
Detection of Epstein-Barr virus in children and adolescents with Burkitt's lymphoma by in situ hybridization using tissue microarrays. Hematology (2008) 0.80
Immunohistochemical assessment of mucosal cytokine profile in acetic acid experimental colitis. Clinics (Sao Paulo) (2005) 0.80
Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland. Oral Oncol (2008) 0.80
MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma. Cancer Epidemiol (2009) 0.80
Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs. PLoS One (2013) 0.80
Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas. Virchows Arch (2013) 0.80
Prion protein ablation increases cellular aggregation and embolization contributing to mechanisms of metastasis. Int J Cancer (2009) 0.80
Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast. Clinics (Sao Paulo) (2013) 0.80
Analysis of human kallikrein 7 expression as a potential biomarker in cervical neoplasia. Int J Cancer (2010) 0.79
Relationship between B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) and homologous recombination regulatory genes in invasive ductal breast carcinomas. Histol Histopathol (2012) 0.79
Follicular lymphoma in the palate with clinical appearance similar to salivary gland tumors. Quintessence Int (2010) 0.79